ÂÜÀòÂÒÂ×

Mijanou van der Woude is the Vice President for Operations at Intersect Diagnostics, where she is responsible for procurement, lab infrastructure, and project management. Prior to joining Intersect Diagnostics, Ms. van der Woude worked as Site Director for the Los Angeles facility of Cancer Genetics, Inc. (NASDAQ: CGIX), where she led operations for three years, including managing regulatory audits as well as site qualifications and inspections commensurate with Good Clinical Practice (GCP) requirements. Prior to that, Ms. van der Woude served for over 10 years as a skilled manager in companies in various industries managing their strategic growth and success.